CN Patent

CN101888828A — 脉冲胃滞留剂型

Assigned to Assertio Holdings Inc · Expires 2010-11-17 · 15y expired

What this patent protects

描述了用于向胃延迟释放或脉冲释放治疗剂的剂型。该剂型是胃滞留剂型，其实现了在施用该剂型后治疗剂向胃和上胃肠道的释放。该剂型在施用酸不稳定性活性剂，诸如质子泵抑制剂中，以及在治疗胃酸分泌，诸如胃食道反流疾病(GERD)和夜间酸突破(NAB)中具有特定用途。

USPTO Abstract

描述了用于向胃延迟释放或脉冲释放治疗剂的剂型。该剂型是胃滞留剂型，其实现了在施用该剂型后治疗剂向胃和上胃肠道的释放。该剂型在施用酸不稳定性活性剂，诸如质子泵抑制剂中，以及在治疗胃酸分泌，诸如胃食道反流疾病(GERD)和夜间酸突破(NAB)中具有特定用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN101888828A
Jurisdiction
CN
Classification
—
Expires
2010-11-17
Drug substance claim
No
Drug product claim
No
Assignee
Assertio Holdings Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.